Inhibition of calcium channels by opioid- and adenosine-receptor agonists in neurons of the nucleus accumbens

Br J Pharmacol. 2001 Jun;133(3):337-44. doi: 10.1038/sj.bjp.0704072.

Abstract

The pharmacological effects of opioid- and adenosine-receptor agonists on neural signalling were investigated by measuring drug actions on barium current flowing through calcium channels in acutely-dissociated neurons of the rat nucleus accumbens (NAc). Under whole-cell voltage clamp, opioids acted via mu, but not delta or kappa, receptors to partially inhibit barium current. Mean inhibition was 35+/-2% (+/-s.e.mean, n = 33) for methionine-enkephalin and 37+/-1% (n = 65) for the selective mu receptor agonist DAMGO, both measured at saturating agonist concentrations in neurons with diameter > or = 20 microm. EC(50) for DAMGO was 100 nM. Perfusion of naloxone reversed the current inhibition by DAMGO. Adenosine also partially inhibited barium current in these neurons. Mean inhibition was 28+/-2% (n = 29) for adenosine and 33+/-3% (n = 27) for the selective A1 receptor agonist N(6)CPA, both at saturating concentrations in neurons with diameter > or = 20 microm. EC(50) for N(6)CPA was 34 nM. Adenosine inhibition was reversed by perfusion of an A1 receptor antagonist, 8-cyclopentyl-1,3-dipropylxanthine, while the selective A2A receptor agonist, CGS 21680, had no effect. Inhibition by opioids and adenosine was mutually occlusive, suggesting a converging pathway onto calcium channels. These actions involved a G-protein-coupled mechanism, as demonstrated by the partial relief of inhibition by strong depolarization and by the application of N-ethylmaleimide or GTP-gamma-S. Inhibition of barium current by opioids had their greatest effect in large neurons, that is, in presumed interneurons. In contrast, opioid inhibition in neurons with diameter < or = 15 microm was 11+/-2% (n = 26) for methionine-enkephalin and 11+/-4% (n = 17) for DAMGO, both measured at saturating agonist concentrations. Adenosine inhibition in neurons with diameter < or = 15 microm was 22+/-5% (n = 9). These results implicate the interneurons as a locus for the modulation of the excitability of projection neurons in the NAc during the processes of addiction and withdrawal.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine / pharmacology
  • Analgesics, Opioid / pharmacology
  • Animals
  • Barium / metabolism
  • Calcium Channel Blockers / pharmacology*
  • Calcium Channels / metabolism*
  • Cell Size
  • Electrophysiology
  • Enkephalin, Ala(2)-MePhe(4)-Gly(5)- / pharmacology
  • Enkephalin, D-Penicillamine (2,5)- / pharmacology
  • Ethylmaleimide / pharmacology
  • Guanosine 5'-O-(3-Thiotriphosphate) / pharmacology
  • Heterotrimeric GTP-Binding Proteins / metabolism
  • Interneurons / drug effects
  • Interneurons / metabolism
  • Ion Channel Gating / drug effects*
  • Naloxone / pharmacology
  • Narcotic Antagonists / pharmacology
  • Neostriatum / drug effects
  • Neostriatum / metabolism
  • Neurons / cytology
  • Neurons / drug effects*
  • Neurons / metabolism
  • Nucleus Accumbens / cytology
  • Nucleus Accumbens / drug effects*
  • Nucleus Accumbens / metabolism
  • Purinergic P1 Receptor Agonists*
  • Purinergic P1 Receptor Antagonists
  • Rats
  • Rats, Wistar
  • Receptors, Opioid / agonists*
  • Receptors, Opioid / metabolism
  • Receptors, Purinergic P1 / metabolism
  • Signal Transduction / drug effects

Substances

  • Analgesics, Opioid
  • Calcium Channel Blockers
  • Calcium Channels
  • Narcotic Antagonists
  • Purinergic P1 Receptor Agonists
  • Purinergic P1 Receptor Antagonists
  • Receptors, Opioid
  • Receptors, Purinergic P1
  • Enkephalin, Ala(2)-MePhe(4)-Gly(5)-
  • Barium
  • Naloxone
  • Guanosine 5'-O-(3-Thiotriphosphate)
  • Enkephalin, D-Penicillamine (2,5)-
  • Heterotrimeric GTP-Binding Proteins
  • Adenosine
  • Ethylmaleimide